Here’s Why the Fund Exits Dolby Laboratories (DLB)
Aristotle/Saul Global Equity Fund, sub-advised by Aristotle Capital Management, LLC, released its second-quarter 2026 investor letter. The letter can be downloaded here.
Dolby Laboratories Inc. (DLB)
Market is closed
Sector: Patent Owners & Lessors
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Citadel Investment Group Ken Griffin | 582,031 | $30,603,190 | +1544% | 0% |
| 2. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 527,158 | $27,717,968 | +324% | 0.01% |
| 3. | Millennium Management Israel Englander | 420,067 | $22,087,123 | -3% | 0.01% |
| 4. | D E Shaw D. E. Shaw | 415,005 | $21,820,963 | +6% | 0.01% |
| 5. | Marshall Wace LLP Paul Marshall And Ian Wace | 343,678 | $18,070,591 | +465% | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $78.15 | 3 | $200.00 | 3 | 2024-06-17 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $59.33 | 836 | $49,597.79 | 166,803 | 2026-10-01 | Filing | |
| $58.72 | 6,831 | $401,091.73 | 167,639 | 2026-10-01 | Filing | |
| $61.05 | 7,667 | $468,032.02 | 118,727 | 2026-09-01 | Filing | |
| $65.28 | 1,183 | $77,223.05 | 34,453 | 2026-08-25 | Filing | |
| $62.71 | 3,000 | $188,130.00 | 73,274 | 2026-08-14 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 217 | $12,753 | 0% | |
| 2. | 142 | $8,345 | 0% | |
| 3. | 101 | $5,936 | 0% | |
| 4. | 72 | $4,232 | 0% | |
| 5. | 13,074 | $768 | 0.02% |
News See All
Here’s Why Dolby Laboratories (DLB) Traded Down in Q2
Cambiar SMID Fund, managed by Cambiar Investors, published its Q2 2026 investor letter. The letter can be downloaded here. U.S.
Can Rising Component Costs and Weak Consumer Spending Break Dolby Laboratories' (DLB) Growth Outlook?
Prosper Stars & Stripes, a long/short equity fund, recently released its second-quarter 2026 investor letter. The letter can be downloaded here.
Dolby Laboratories, Inc. (NYSE:DLB) Q2 2026 Earnings Call Transcript
Dolby Laboratories, Inc. (NYSE:DLB) Q2 2026 Earnings Call Transcript May 1, 2026 Operator: Ladies and gentlemen, thank you for standing by.
Dolby Laboratories, Inc. (NYSE:DLB) Q1 2026 Earnings Call Transcript
Dolby Laboratories, Inc. (NYSE:DLB) Q1 2026 Earnings Call Transcript January 29, 2026Dolby Laboratories, Inc. beats earnings expectations. Reported EPS is $1.06, expectations were $0.993.
Do You Believe in the Growth Potential of Dolby Laboratories (DLB)?
Aristotle Capital Boston, LLC, an investment advisor, released its “Small Cap Equity Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Dolby Laboratories, Inc. (NYSE:DLB) Q4 2025 Earnings Call Transcript
Dolby Laboratories, Inc. (NYSE:DLB) Q4 2025 Earnings Call Transcript November 18, 2025Dolby Laboratories, Inc. beats earnings expectations. Reported EPS is $0.99, expectations were $0.7.
Dolby Laboratories, Inc. (NYSE:DLB) Q3 2025 Earnings Call Transcript
Dolby Laboratories, Inc. (NYSE:DLB) Q3 2025 Earnings Call Transcript July 31, 2025Dolby Laboratories, Inc. beats earnings expectations. Reported EPS is $0.78, expectations were $0.72.
Does Dolby Laboratories (DLB) have an Enhanced Margin Potential?
Aristotle Capital Boston, LLC, an investment advisor, released its “Small/Mid Cap Equity Strategy” second quarter 2025 investor letter. A copy of the letter can be downloaded here.
Dolby Laboratories, Inc. (NYSE:DLB) Q2 2025 Earnings Call Transcript
Dolby Laboratories, Inc. (NYSE:DLB) Q2 2025 Earnings Call Transcript May 1, 2025Dolby Laboratories, Inc. beats earnings expectations. Reported EPS is $1.34, expectations were $1.29.
Hedge Fund Resource Center